chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Beginning in January 1987, I experienced recurring fevers, sweats, muscle aches, fatigue, sore throat, heart arrhythmias, lack of energy, as well as other symptoms.
Its been more than 42 days since 1st dose; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (Its been more than 42 days since 1st dose) in a 54-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Mar-2021, the patient experienced PRODUCT DOSE OMISSION ISSUE (Its been more than 42 days since 1st dose). On 11-Mar-2021, PRODUCT DOSE OMISSION ISSUE (Its been more than 42 days since 1st dose) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications provided. Patient was advised not to take the second dose while on antibiotics. No treatment details reported.
About 3 hours after the vaccine I became incredibly anxious and forgetful. Began locking myself out of the house and other things that I normally wouldn't do. I have not mentioned the anxiety and forgetfulness to my PCP. Since my vaccine I have also been having high ALT values when my PCP ran liver test.
In the 2 days following the vaccination, there was some localized swelling and discomfort. About 3 days later, I noticed tenderness and bumpy area surrounding the injection site. Bruising began about 5 days later. Scattered areas of bruising and tenderness in a radius of about 2 inches of the injection site. The bumpy areas continued, and tenderness seemed to increase. As of today, the left upper arm is scabby, oozing, and discolored. Tenderness is continuing. I plan to see my PCP tomorrow. I have photos to document the reaction.
Client received second dose of Pfizer Lot EP7534 COVID vaccine prior to 21 day window
Information has been received from a lawyer regarding a case in litigation concerning a female patient of unknown age. No information was received regarding the patient's past medical history, concurrent conditions, or concomitant medication. In 2016 the patient was inoculated with the ZOSTAVAX (lot number, dosage and route of administration not provided), as recommended for routine adult health maintenance for the prevention of shingles. The ZOSTAVAX did not prevent shingles or zoster-related injuries as intended, and on an unknown date the patient subsequently contracted zoster-related vision loss and other complications. The patient was treated at a medical center for vision loss. As a direct and proximate result of the ZOSTAVAX vaccine, and/or despite receiving ZOSTAVAX for the long-term prevention of shingles, the patient suffered injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. The outcome of the events was considered to be not recovered.  Zoster-related vision loss was considered to be medically significant. Additional information has been requested.
Ache bones and joints, acid reflux, Agitation, high cholesterol, blood pressure spikes and drops, cramps legs, dizziness, blood pressure high, feeling sluggish and hung over when no alcohol consumed, flatulence (passing gas), flu-like symptoms, gastritis, angina, energy loss, numbness and tingling arms and down one side of body, pain legs, pain lower back, pain back, pain through his body, stomach pain, pain bone and joint, pain neck, itching dry and flaky skin, infection with rash, chest pain, pains in feet like electrical shocks, charlie horse, insomnia, sleep problems, shifting sleep patterns, vertigo, blurred vision, testicular failure.
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 66-year-old female patient (not pregnant) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 22Oct2022 as dose 5 (booster), single (Lot number: Cj6665) at the age of 65 years, in left arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown), as dose 3 (booster), single (Batch/Lot number: unknown) and as dose 4 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset Dec2022, outcome "unknown" and all described as "COVID 19 Treatment". Therapeutic measures were taken as a result of drug ineffective, covid-19: the patient received Paxlovid from 23Dec2022 to 27Dec2022 for COVID-19 treatment.  No follow-up attempts are possible. No further information is expected.
Within 1 month of second dose, dyspnea episodes, leading to onset of major issues beginning February 2022. Volume overload, plural effusion,  dyspnea, orthopnea, inflammation, constrictive pericarditis, liver cirrhosis, diagnosed with idiopathic polyserositis 11/2022, upcoming open-heart surgery for pericardiectomy.
Pt reports having following symptoms: poking in the throat, headace, fatigue, dizzy, feeling out of it, coughs, and runny nose; pt described it as "strong cold-like symptoms" all started on Wednesday 4/14/2021 in the morning time (over a 1.5 week of post-vaccination).   What happened as a result of the adverse event? Pt reported she started taking Tylenol on 4/15/2021 PRN for her headache which helped; reports staying hydrated by drinking plenty of water and hot tea. Pt reports she is going to get tested for covid-19 today.   ***NOTES*** Advised pt that symptoms such as coughs and runny nose are symptoms or covid-19 or another infection which are not consistent with post-vaccination symptoms. Recommend pt to contact her MD if her symptoms are not getting better and to continue to stay hydrated. Advised pt if her covid-19 test results comes back positive, recommend pt to quarantine for 14 days. Advised pt that if she tested positive for covid-19 and is still experiencing covid symptoms or not feeling well to make sure she recovers and complete her quarantine period before getting her second dose. Provided pt with contact information to reschedule her 2nd dose if needed.
metallic taste; This is a spontaneous report from a contactable nurse.  This nurse reported similar events for two patients.  This is the first of two reports.  A patient of unspecified age and gender received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), via an unspecified route of administration, in Dec2020 at a single dose for COVID-19 immunization.  The patient's medical history and concomitant medications were not reported.  The patient experienced metallic taste in Dec2020.  The clinical outcome of metallic taste was unknown.    The batch/lot number for the vaccine, BNT162B2, was not provided and will be requested during follow-up.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2020504716 same reporter/drug/event, different patient
Feel awful; This case was reported by a consumer via interactive digital media and described the occurrence of feels awful in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 2nd dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced feels awful. On an unknown date, the outcome of the feels awful was unknown.   The reporter considered the feels awful to be related to Shingles vaccine.  Additional details were provided as follows: The case was reported by patient. The age at vaccination was not reported. The patient stated second shingles shot made him/her feel awful.  The patient was glad that he/she got vaccine. The follow-up would not possible as no contact details were available.
pt recv vax 22JUN95 & 17MAR97 pt exp full blown chickenpox w/over 50 lesions;
Has flares up a little in the evening; he developed hives on both arms/Hives on both forearms; he developed itching on the arms/Arm started itching; This is a spontaneous report from a contactable consumer.  A 69-years-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection. Lot Number: EN6201; Expiration Date: 30Jun2021), dose 1 via an unspecified route of administration, administered in right arm on 08Feb2021 at 14:00 (at the age of 69-years-old) as dose 1, single for COVID-19 immunization. The patient medical history was not reported. The patient had no family medical history. The patient concomitatnt mediaction were reported as none. The pateint previously received aloe (aloe extract) for itching and inflammation; influenza virus vaccine in Nov2020 and expereinced sore arms; pneumococcal vaccine in Nov2020 and expereinced sore arms. The patient received Levofloxacin in Jun2019 and expereinced hives. It was reported that patient had hives before from an antibiotic, Levofloxacin, which was much more severe. Hives were on legs, arms, and everywhere. Aloe can control the itching and the aloe kept the inflammation down. Experienced this 1.5 years ago and discovered that aloe works. Indication: Notified by medical provider and because patient was over 65 he was eligible to set up an appointment. Only thing that might be relevant was the Levofloxacin and if that has a similar product in it as the COVID-19 Vaccine. Reaction occurred in Jun2019. Only took Levofloxacin for a few days and broke out in hives. Believed he discarded the Levofloxacin. Clarified Aloe was over the counter. On 12Feb2021, patient developed itching on the arms. On 13Feb2021, patient developed hives on both arms. It was reported that, patient was able to manage adverse events with lotion. Considering that the adverse events showed up 4 days later, patient wanted to Knew that, was it safe to take the second dose. On 17Feb2021, Patient was sure that he had a side effect from the COVID-19 vaccine. It was reported that, hives have been manageable and patient had been putting Aloe on it. Used it a couple times a day. Keeps the itch down. Has flares up a little in the evening, but it was manageable. It was almost all but disappeared by now, Knew what hives could turn into. Wanted to see if it makes sense to get the second dose. The outcome of the events were recovering.   No follow up attempts are possible. No further information is expected.
Flu injection was administered into arm and syringe would not plunge. Because there was a lot of resistance, nurse pulled back out syringe & needle. Nurse obtained new needle & syringe and offered to administer the vaccine in the other arm. Patient declined the other arm and gave approval to try again same arm.  A new vaccine was obtained & administered in the same arm. Patient returned the next day, complaining about pain in her arm and decreased range of motion. Upon observation, the pokes were observed to be possibly too high. She was trying Ibuprofen and ice.  When the pain did not improve, she sought medical care outside the facility. The treatments and outcome of the situation are not known to this nurse.
Covid vaccine breakthrough event   MCIR also listed Moderna vaccine given on 5/15/21
Chest started hurting; Hurt under his arm; It was moving around and stomach and everything; It was moving around and stomach and everything; This spontaneous case was reported by a patient family member or friend and describes the occurrence of CHEST PAIN (Chest started hurting), PAIN IN EXTREMITY (Hurt under his arm), ABDOMINAL PAIN UPPER (It was moving around and stomach and everything) and PAIN (It was moving around and stomach and everything) in a male patient of an unknown age who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 prophylaxis.     No Medical History information was reported.    On 02-Nov-2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 03-Nov-2022, the patient experienced CHEST PAIN (Chest started hurting), PAIN IN EXTREMITY (Hurt under his arm), ABDOMINAL PAIN UPPER (It was moving around and stomach and everything) and PAIN (It was moving around and stomach and everything). At the time of the report, CHEST PAIN (Chest started hurting), PAIN IN EXTREMITY (Hurt under his arm), ABDOMINAL PAIN UPPER (It was moving around and stomach and everything) and PAIN (It was moving around and stomach and everything) outcome was unknown.            No concomitant medications were reported. On 02-Nov-2022, patient had received Moderna booster dose. The reporter wanted to know if they need to take patient to the hospital. No treatment details were reported.
24FEB91 developed pruritis of lt upper arm; red, warm, edematous area; 25FEB91 To hlth dept seen by RN 3" area of reddness, edema, warm to touch;
received GARDASIL 9 in the buttocks; no additional AE reported; This spontaneous report was received from an office manager who was a patient's mother via vaccine account representative and refers to a female patient of unknown age. No information on patient's pertinent medical history, drug reactions/ allergies and concomitant medications was provided.  On an unknown date, the patient was vaccinated with a dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) (lot #, expiration date, dose, route of administration were not reported) in the buttocks for prophylaxis. No additional adverse events reported.
This spontaneous report as received from a medical assistant refers to multiple unspecified patients of unknown age and gender. Information regarding relevant medical history, concurrent condition and concomitant medications were not reported. On unknown dates, the patients were vaccinated with improperly stored VAQTA (lot # L015460, expiration date 20-JUL-2017, dose and route not reported). No adverse effects reported. This is one of several reports received from the same source. Additional information is not expected because we are not allowed to contact the reporter.
My child got vaccinated on August 4, 2021 , the next day on the 5th he started experiencing fatigue, soreness, pain all over his back , and headache . He woke me up around 12:02 am the next day on August 6th and was complaining of extreme pain in his chest , felt like his heart was going to jump out. It lasted for about 30 minutes,  then went away . Later that day , he experienced some more chest pain . He has since been experiencing the same chest pain and also heaviness in his left arm .  He continues to have the pain in his chest here and there but not the arm pain.
Patient stated after receiving her first dose of Pfizer she experienced eye pain/burning a day after the vaccine which lasted 2 days. She had eye surgery on both eyes 15 years ago and believes it wasn't due to the eye surgery. Patient has since recovered and didn't follow up with PCP
No adverse reaction, spoke with the patient's mother on today 06/08/2021 and she stated she is fine. Vaccine given outside label recommendation.
pt recv vax OCT96 & devel hives pt was treated w/DPH & recovered;this case was reported by a MD;
14 year old (previously health) (no recent history of URIs or trauma)- History significant for fact that she received Gardasil at clinic on 6/27/08 (2nd dose- first dose in April 2008)- On 6/28/08 patient with acute onset severe headache, left arm pain(paralysis)- leading to parents to call 911- by the time ambulance arrived patient with flaccid paralysis and asystolic event in ambulance requiring atropine IV-- currently in ICU with bilateral upper and lower extremity paralysis and respiratory failure (ventilated)-- diagnosed with : classic transverse myelitis currently of unknown etiology8/28/08-records received-presented to ED on 6/28/08 with acute onset of flaccid paralysis, sudden onset of severe headache on day of presentation followed by arm pain. Shortly thereafter lost tone in all extremities. Intubated in field and went into asystole. Placed on ventilator. Hospital course complicated by right sided pleural effusion and pneumothorax requiring placement of chest tube. DX with aspiration pneumonia. Nasogastric tube insertion. Unable to be extubated. Respiratory alkalosis. Plasmapheresis. PE on 7/7/08 no change since admission. Dyspnea. DX:transverse myelitis of unknown etiology, intubated secondary to respiratory failure with persistent sensation of air hunger. 9/10/08-DC Summary received for DOS 6/28-8/7/08- DX:Transverse myelitis. Plasmapheresis. Etiology of transverse myelitis was negative.  Re-developed temperature and deep touch sensation in extremities, three weeks after event regained deep tendon reflexes and positive Babinski sign bilaterally. Neuropathic pain. Tracheostomy and mechanical ventilation. Asystole of unknown etiology. Transferred to rehabilitation facility.
Cardiac arrest resulting in death.  I actually do not know the name of the vaccine or which type it was it was her 2nd one and it occurred today at 1:30 pm
Diarrhea with loose stools 2-3 times a day.  Symptoms came on about 36 hours after vaccine administration with associated myalgias, malaise/fatigue.  The other symptoms resolved within a few days but loose stools persist over 3 weeks.
FLUZONE quadrivalent admin 10-25-13 at approx. 0715. 10-26-13 am Severe swelling entire arm vaccinated side and entire leg same side. 10-27-13 - fever.
12/30/21 started with headache within hour of getting vaccine, by that night with fatigue and feeling unwell 1/1/21 woke up at 0600 with slight dizziness, brain fog, fatigue, headache 1/2/21 Intense vertigo that progressively worsened throughout the day, vomited once around 5pm, also headache, brain fog, fatigue 1/3/21 still with vertigo, brain fog, fatigue, HA but not as severe but had to rest all day 1/4-1/11/21 no longer with headache but cont with vertigo, brain fog, fuzzy headed feeling persisting
Severe swelling, itchiness, redness, hot to the touch, at the injection site. Low grade fever by the afternoon (100.4).
This spontaneous report was received from a Registered Nurse and refers to multiple unspecified patients of unknown age and gender. Patient's concurrent conditions, medical history and concomitant medications were unknown. It was reported that doses of ROTATEQ Lot # K004432, expiry date 27-JAN-2016; lot # L000434, expiry date 10-JUL-2016; lot # L006184, expiry date 13-DEC-2016, lot # L020859, expiry date 19-JAN-2017; lot # K004922, 26-FEB-2016; (dose was not reported) that were exposed for 2 hours at 34.4 F and then back in the range, were given to unspecified patients on unspecified dates. It was also confirmed that the vaccine had no previous temperature excursion. No adverse effects were reported. No product quality complaint (PQC) was involved. It was unknown if the patients sought medical attention. This is one of several reports received from the same source. Lot number K004922 has been verified to be a valid lot number for Rotavirus vaccine, live, oral, Pentavalent. Additional information has been requested.
Low grade fever; This spontaneous case was reported by an other and describes the occurrence of PYREXIA (Low grade fever) in a 24-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Crohn's disease.   On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 05-Mar-2021, the patient experienced PYREXIA (Low grade fever). On 06-Mar-2021, PYREXIA (Low grade fever) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered PYREXIA (Low grade fever) to be probably related.
Service member reports that bradycardiac and presyncopal/syncopal episodes developed 2 weeks after receiving the H1N1 vaccine from a multidose vial in March 2010. She states she was healthy before receiving the vaccine with no medical problems and no chronic medications. Patient has been hospitalized 6 x since March 2010 with these incidents and once received atropine by EMS. Last hospitalization was 21 Sept for one week where she "passed out and fell down the stairs" after which her roommates called 911. Systemic symptoms other new symptoms are daily headaches with severe migraines with photophobia 1x/month that "puts me in bed for 24 hours." Is "lethargic all the time". And also has pain in the knees, hips and low back, muscle weakness and unrefreshing sleep. She reports easily getting short of breath on exertion such as walking up a flight of stairs. She has poor memory and cognitive dysfunction and is worried that recently she "misplaced words". e.g. putting in words in a sentence that do not belong there. Overall, once/week she feels "that it is going to come". She begins to become extremely exhausted and actually falls asleep sitting or even standing. She goes to bed and drinks copious fluids until she feels better. Once/month she cannot control the symptoms and ends up in the ER. She now reports she sometimes gets a racing heartrate when she stands up; it resolves when she sits down. Recently reports urinary incontinence pad. Also has diarrhea and extremely dry mouth. Treatments: Medications: Midodrine 7.5mg tid, NaCL 1000mg tid, pressure stockings, Depo shot q 3 months, provigil 100mg qd,TYLENOL for headaches, denies all herbs and supps except MVI and Cal/D supps. Symptoms abade with IV fluids. Symptoms: Altered mental status (780.97), diarrhea NOS(787.91), disturbance, sleep NOS (780.50), generalized pain(780. 96), headache (784.0), Malaise and fatigue NEC(780.79), Palpitation(785.1), shortness of breath(786.05), Symptom, memory loss(780.93), Syncope and collapse(780.2). Diagnosis = Orthostatic intolerance, autonomic nervous system disorder.
CHIEF COMPLAINT:   Hx of lupus, c/o 2 days of abd pain. Pt reports hematuria when up to bathroom last night. Also has ostomy, possibly blood in stool in osotomy bag per pt. Liquid stool in bag, brown in color with pink tinge. Pt moaning in triage.   HISTORY OF PRESENT ILLNESS:     Patient presenting to the emergency department with blood in urine and possibly blood in the stool patient also states she has had epigastric pain that has been worsening over the last 5 days.  Patient has a history of lupus as well as antiphospholipid syndrome.  Patient states that her ostomy bag has been mostly liquid stool.  Denies chest pain.  Patient does states she has pain in the mid lower back.  Patient has fevers chills.  Patient also has been having nausea no vomiting.  Nursing note reviewed.  Patient seen during the Covid pandemic.
pt vomited 25 mins p/vax was given; had stomache ache was pale, sweating; pt kept in the office x 35 mins & BP & pulse monitored;
severe maiaise, shivering, body aches, headache.   Started a few hours after vaccination, much better after 36 hrs of time of injection.